Page last updated: 2024-08-21

nicotinamide mononucleotide and Overweight

nicotinamide mononucleotide has been researched along with Overweight in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Apte, RS; Bhargava, A; Bhasin, S; Cheng, M; Ghattas-Puylara, C; Latham, N; Lavu, S; Lawney, B; Lin, AP; Livingston, D; Memish-Beleva, Y; Merugumala, S; Orkaby, AR; Ozimek, NE; Pencina, KM; Reid, KF; Sinclair, DA; Storer, T; Swain, PM; Valderrabano, R; Wilson, L; Wipper, B1
Franczyk, MP; Imai, SI; Kayser, BD; Klein, S; Mills, KF; Patterson, BW; Patti, GJ; Pietka, T; Sindelar, M; Yoshino, J; Yoshino, M1
Fischer-Posovszky, P; Roos, J; Zinngrebe, J1

Trials

2 trial(s) available for nicotinamide mononucleotide and Overweight

ArticleYear
Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study.
    The Journal of clinical endocrinology and metabolism, 2023, Jul-14, Volume: 108, Issue:8

    Topics: Aged; Body Weight; Cholesterol; Humans; Insulin Resistance; Middle Aged; NAD; Nicotinamide Mononucleotide; Obesity; Overweight

2023
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
    Science (New York, N.Y.), 2021, 06-11, Volume: 372, Issue:6547

    Topics: Aged; Body Composition; Dietary Supplements; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Overweight; Postmenopause; Prediabetic State; RNA-Seq; Signal Transduction

2021

Other Studies

1 other study(ies) available for nicotinamide mononucleotide and Overweight

ArticleYear
Nicotinamide mononucleotide: a potential effective natural compound against insulin resistance.
    Signal transduction and targeted therapy, 2021, 08-19, Volume: 6, Issue:1

    Topics: Biological Products; Female; Humans; Insulin; Insulin Resistance; NAD; Nicotinamide Mononucleotide; Overweight; Randomized Controlled Trials as Topic

2021